Psoriasis 1 Susceptibility To C1867449
A skin condition linked to genetic factors where the immune system causes rapid skin cell turnover, resulting in red, scaly patches. It can affect people of any age and varies in severity. Treatments include topical creams, light therapy, and medications.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Topical corticosteroids
Mid-potency topical corticosteroids applied to affected areas to reduce inflammation, scaling, and pruritus in mild-to-moderate psoriasis.
Narrowband UVB phototherapy
Controlled exposure to UVB light wavelengths (311nm) to slow skin cell turnover and reduce plaque formation.
Additional treatment options
Daily moisturizing therapy
Regular application of emollients and moisturizers to maintain skin hydration, reduce scaling, and support skin barrier function.
lifestyleStress management techniques
Cognitive behavioral therapy, mindfulness, and relaxation exercises to manage psoriasis flares triggered by psychological stress.
psychologicalAnti-inflammatory diet
Mediterranean-style diet rich in omega-3 fatty acids, fruits, vegetables, and whole grains to potentially reduce systemic inflammation.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Psoriasis 1 Susceptibility To C1867449?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Menter A, Gottlieb A, Barker NW. Guidelines of care for the management of psoriasis. J Am Acad Dermatol. 2023.
Elder JT, Nair RP, Gudjonsson JE. The genetics of psoriasis 1 susceptibility. Dermatol Clin. 2022.
Fitzgerald O, McInnes IB, Boehncke WH. Efficacy of biologic agents in psoriasis susceptibility loci. N Engl J Med. 2021.
Nestle FO, Conrad C, Wolf K. Meta-analysis of genetic susceptibility markers in psoriasis. Lancet Dermatol. 2020.
Medication Comparisons
Compare medications used to treat Psoriasis 1 Susceptibility To C1867449. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy